Bristol-Myers Squibb Co., Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
J Pharm Biomed Anal. 2011 Feb 20;54(3):602-6. doi: 10.1016/j.jpba.2010.09.031. Epub 2010 Oct 30.
Pyrazinones bearing an N-1-alkyl chain with a chiral center have been reported as potent antagonists of the corticotropin-releasing factor-1 receptor (CRF1R). Separation of individual enantiomers for preclinical testing was an important aspect of lead optimization. To evaluate the applicability and efficiency of supercritical fluid chromatography (SFC) for enantiomeric resolution of this class of compounds, enantiomeric pairs of eight pyrazinones with different structural characteristics were tested under an array of SFC conditions. The results showed that pyrazinones with a 1-cyclopropyl-2-methoxyethyl substituent were readily separated with a Chiralpak AD-H or Chiralcel OD-H column with ethanol as the modifier. On the other hand, analogs with a less polar alkyl substituent were not amenable to the general method and required further optimization of the chromatographic conditions. In addition, structural variations on the pyrazinone core and aromatic moiety had an impact on the chiral resolution of this class of compounds. This investigation led to the development of efficient chiral SFC methods for separating all eight pyrazinone enantiomeric pairs encompassing an array of structural variations.
具有手性中心的 N-1-烷基链的吡嗪酮已被报道为促肾上腺皮质释放因子-1 受体 (CRF1R) 的有效拮抗剂。为了进行临床前测试,将单个对映异构体分离出来是优化先导化合物的重要方面。为了评估超临界流体色谱 (SFC) 在这类化合物对映体拆分中的适用性和效率,在一系列 SFC 条件下测试了具有不同结构特征的 8 对对映体吡嗪酮。结果表明,具有 1-环丙基-2-甲氧基乙基取代基的吡嗪酮可以用 Chiralpak AD-H 或 Chiralcel OD-H 柱很容易地分离,以乙醇作为修饰剂。另一方面,烷基取代基极性较小的类似物不适合一般方法,需要进一步优化色谱条件。此外,吡嗪酮核和芳基部分的结构变化对这类化合物的手性拆分有影响。这项研究导致开发了有效的手性 SFC 方法,可用于分离涵盖各种结构变化的所有 8 对对映体吡嗪酮。